Chromogranins A (CgA) and B (CgB) are acidic proteins contained in the secretory granules of many endocrine and neuroendocrine cells and secreted with the co-resident hormones (Winkler and Fisher-Colbrie, 1992) . cDNA sequence analysis and biochemical studies have shown that CgA and CgB are hydrophilic proteins, 439 and 657 residues long, respectively, with a high proportion of acidic amino acids Konecki et al., 1987; Helman et al., 1988; Wu et al., 1991) . Both proteins are characterised by several post-translational modifications including glycosylation, sulphation and phosphorylation (Simon and Aunis, 1989; Winkler and Fisher-Colbrie, 1992) . Although the specific intracellular and extracellular function of CgA is not yet clearly understood, it is thought that this protein is a multivalent precursor of several polypeptides that may exert intracrine, autocrine, paracrine and endocrine effects (Helle and Angeletti, 1994) . Accordingly, CgA contains a high number of dibasic sites thought to be important for proteolytic processing and biological activity (Metz-Boutigue et al., 1993) .
CgA has been recognised as a useful tissue marker for a variety of endocrine cells (Deftos et al., 1988; Weiler et al., 1987; Totsch et al., 1992; Rosa and Gerdes, 1994) . Moreover, since increased levels of CgA have been found in the blood of some patients with endocrine and neuroendocrine tumours (O'Connor and Bernstein, 1984; Sobol et al., 1986; Deftos, 1991; Johnson et al., 1993) , detection of CgA antigen in serum could be of great clinical and experimental interest.
In this work we have characterised the structure of circulating CgA forms in phaeochromocytoma patients, using chromatographic, electrophoretic cells, cultured in RPMI, 20% fetal calf serum (FCS), 2 mM glutamine, 100 U ml-' penicillin, 100 jug ml-' streptomycin, 25 jug ml-' amphotericin B, at 37°C, 5% carbon dioxide.
Phaeochromocytoma and VIPoma heat-stable fractions (HSFs) were prepared as follows: tissues were frozen in liquid nitrogen immediately after surgical excision, lyophilised and homogenised in distilled water. The homogenate was boiled for 6 min and centrifuged at 120 000 g for 30 min. The supernatants containing CgA and CgB, which are heat stable (Rosa and Gerdes, 1994) , were kept at -20°C until use. Protein concentration was measured using the 'BioRad Protein Assay' kit.
Peripheral blood from healthy controls (n = 22) was anticoagulated with EDTA (5 mM) or sodium citrate (129 mM), kept in ice and centrifuged at 900 g at 4'C for 20 min. Serum samples were also prepared from the blood of the same subjects (n = 22). Preoperative (n = 7) and postoperative (n = 2) sera were obtained from patients with documented phaeochromocytoma. All plasma and serum samples were stored at -20°C. Milstein, 1981) .
Hybridomas secreting anti-chromogranin A antibodies were screened by ELISA as described (Pelagi et al., 1989) . One clone, named B4E11, was selected for further characterisation and use.
Anti-phaeochromocytoma HSF IgGs were obtained from the sera of two mice immunised with phaeochromocytoma HSF as described (Pelagi et al., 1989 Figure 1 . PVC microtitre plates were coated with B4E1 1 (10 jug ml-' in PBS, 50 Ml per well, overnight at 4°C). All subsequent steps were carried out at room temperature. After washing three times with PBS, the plates were blocked with 3% bovine serum albumin (BSA) Figure 1 . As shown, CgA M-ELISA is based on a sandwich reaction between two monoclonal antibodies (B4Ell and Al1), while the CgA P-ELISA is based on one monoclonal antibody (B4E11) and biotinylated mouse anti-phaeochromocytoma HSF polyclonal IgGs.
To verify the specificity of each assay for CgA, the reactivity of purified CgA and CgB was analysed. The crossreactivity of CgB in the CgA M-ELISA and P-ELISA was less than 0.1%, indicating that these assays can be reliably used for measuring CgA even in the presence of CgB.
Detection of CgA antigens in serum and plasma The CgA content in the serum and plasma of human cancer patients was first measured by P-and M-ELISA. In agreement with previous findings (O 'Connor and Bernstein, 1984; O'Connor and Deftos, 1986) , the results indicate that CgA levels, as measured by both assays, are increased in phaeochromocytoma patients in comparison with normal subjects (Table I) . Moreover, CgA levels decreased to normal values after tumour surgery, suggesting that CgA antigen, as measured by P-and M-ELISA, could be a useful tumour marker. However, the ratio between CgA values measured by M-and P-ELISA ('P/M ratio') was different in different patients ranging from 0.45 to 2.8. This suggests that the biological fluids examined contain different antigenic forms that are differentially recognised by different assays. Of note, some variability in the P/M ratio was observed, though to a lower extent, within serum samples from normal subjects (from 1.5 to 2.12) and plasma samples (from 1.3 to 2.1).
Assay validation studies showed that P-ELISA intra-assay (n =10) and interassay (n = 6) coefficient of variation (CV), was 5.2% and 22.5%, respectively, as determined using ten serum samples from normal subjects and patients. Similarly, M-ELISA intra-assay CV was 6.3%, while interassay CV was 19.5%. To evaluate the parallelism of response between sera and standards, four serum samples were analysed at 1: 3 and 1:6 dilution. The values obtained by P-ELISA and M-ELISA at 1: 6 dilution were 96.0 + 3.9% and 121 + 47.8% different assays, the molecular weight of serum and tissue CgA was characterised by SE-HPLC. As shown in Figure 2 , the chromatographic behaviour of CgA present in the serum of different patients was markedly different. In particular, at least three peaks eluting at 600 kDa (CgA-I), 100 kDa (CgA-II) and 55 kDa (CgA-III) were observed, in different proportions, within serum samples from different patients.
Interestingly, the 'P/M ratio' of these sera before chromatography was different, increasing from 0.5 to 2.5 in patients with an increasing proportion of CgA-I. Accordingly, the 'P/M ratio' of isolated fractions ranged from about 2.5 (CgA-I) to 0.5 (CgA-III), suggesting that CgA-I is detected more efficiently by P-ELISA, whereas CgA-III is detected more efficiently by M-ELISA, when compared with the phaeochromocytoma HFS standard. In conclusion, these results suggest that the discrepancies observed with different assays are related to the presence of variable proportions of three forms of CgA characterised by a different behaviour in SE-HPLC.
Other biological samples with a higher content of CgA were then analysed. Interestingly, CgA forms similar to those found with serum samples were obtained by SE-HPLC of crude phaeochromocytoma HSF (used as reference standards in M-and P-ELISA) and immunopurified CgA, while fresh CHP-134 neuroblastoma cell supernatants contained mainly the CgA-I form (Figure 2 , right panels). Also in these cases, the proportion of each form over the total was variable. Moreover, as described above for serum samples, P-ELISA was more efficient in detecting CgA-I, whereas M-ELISA detected more efficiently CgA-III fractions (Figure 3) .
Peak fractions were then analysed by SDS-PAGE under non-reducing conditions and Western blotting with MAb B4E1 1. As shown in Figure 4 , the CgA-I and CgA-II obtained by SE-HPLC of phaeochromocytoma HSF and of one serum sample containing 2-3 jMg ml-' CgA (sample S4) d  and g ). Similarly, the CgA-III was resolved in a main band of about 60 kDa (lanes c and f). Thus, the distinct forms observed by SE -HPLC appear to be made up by polypeptides with a very similar molecular weight. Of note, some bands of lower relative mass probably corresponding to proteolytic fragments, were observed with CgA-I and CgA-II from phaeochromocytoma HSF (lanes b and d) but not with serum or CHP-134 CgA-I (lanes g and h) . We do not know the reason for this behaviour. However, one band of approximately 30 kDa was observed after gel-filtration of phaeochromocytoma HSF (lanes b and d), while it was almost absent in the starting material (lane a) suggesting that this band is related to proteolysis occurring after SE-HPLC.
To assess further the immunochemical properties of CgA forms, the relative binding of CgA-I, -II and -III to MAb Al1 and B4El1 was also examined. These antibodies recognise epitopes located within residues 68-70 (GAK) and 81 -90 (GFEDELSEVL) of CgA, respectively, as mapped using 20 peptides covering most of the CgA sequence and 12 overlapping peptides encompassing the CgA(65-96) sequence (A Corti et al., 1996) . Thus, these antibodies could be used to probe the cognate epitopes in CgA forms. For Table  I , the relative immunoreactivity of these fractions to Al1 and B4E11 was different, suggesting that, in spite of all CgA forms expressing both epitopes, the accessibility or the conformation of the cognate epitopes in these forms are different.
In conclusion, CgA-I, CgA-II and CgA-III, although appearing to be made up of polypeptides with similar molecular weight, are characterised by markedly different hydrodynamic properties and different immunoreactivity.
To investigate whether CgA-I is related to multimeric complexes, other experiments were undertaken. The results can be summarised as follows: a series of ELISA experiments carried out using solid-phase B4E1 1 in the capturing step and biotinylated B4E1 in the detection step (homosandwich ELISA) failed to detect polyvalent aggregated material both in the S4 serum sample and in a phaeochromocytoma HSF solution (Figure 5a and d) , even when detergents were omitted in the assay incubation and washing buffers ( Figure  5b and e). The same results were obtained using MAb All in a similar homosandwich ELISA, whereas strong signals were obtained with control heterosandwich ELISA made up with solid-phase MAb B4E1 1 and biotinylated All as well as with solid phase All and biotinylated B4E1 1 (Figure 5a, b, d and e). To rule out the possibility that complex dissociation occurred during assay incubation, phaeochromocytoma HSF was treated with disuccinimidyl suberate (DSS), a bifunctional reagent widely used to cross-link protein complexes, and analysed again by the homo-and hetero-sandwich ELISAs. Also in this case (Figure 5c ) no signals were (O'Connor and Frigon, 1984) .
Evidence for differential proteolytic processing of CgA in different endocrine cells has been reported (Deftos et al., 1990 , Brandt et al., 1994 . Interestingly, in these reports, gel filtration chromatography studies showed multiple and distinct immunoreactive species of CgA in different cell lines. Although the comparison with our serum CgA forms is difficult, since the molecular weights were not estimated, it is interesting to note that also in this case forms with apparently larger than the '25I-CgA standard, used to calibrate the column, were observed in some cell lines. In view of the hypothesis that CgA is a multihormone precursor, the occurrence of forms with different hydrodynamic properties could have important implications in the regulation of the proteolytic processing of these proteins in different tissues or in blood. For instance, it is possible that specific proteolytic sites are masked or exposed in different forms. Work aimed at investigating the sensitivity of CgA forms to proteases and at elucidating the factors that affect their hydrodynamic behaviours could help in a better understanding of the complex structure-function relationships of chromogranins and of their physiological and pathological roles in normal subjects and tumour patients.
In conclusion, these results suggest that circulating CgA in phaeochromocytoma patients consists of at least three antigenic forms that appear to be made up of polypeptides with similar molecular weight and different hydrodynamic properties and immunoreactivity. Since the ratio of CgA concentrations measured by P-and M-ELISA (P/M ratio) is dependent on the proportion of these forms over the total, differential detection of CgA with these assays in a high number of patients with different tumours may be exploited to study the diagnostic potential of these forms. 
